NINCX
Price
$26.52
Change
+$0.07 (+0.26%)
Updated
Jul 31 closing price
Net Assets
1.45B
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

NINCX vs VSCIX

NINCX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
NINCX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NINCX is a Hold and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. NINCX (1.45B). VSCIX pays higher dividends than NINCX: VSCIX (1.23) vs NINCX (0.00). NINCX was incepted earlier than VSCIX: NINCX (16 years) vs VSCIX (29 years). NINCX (2.07) is less costly to investors than VSCIX (0.03). VSCIX is a more actively managed with annual turnover of: 17.00 vs. NINCX (12.00). NINCX has a lower initial minimum investment than VSCIX: NINCX (1000) vs VSCIX (5000000). NINCX annual gain was more profitable for investors over the last year : 34.48 vs. VSCIX (22.58). VSCIX return over 5 years is better than : 35.13 vs. NINCX (15.30).
NINCXVSCIXNINCX / VSCIX
Total Expense Ratio2.070.036,900%
Annual Report Gross Expense Ratio2.070.036,900%
Fund Existence16 years29 years-
Gain YTD18.81714.591129%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.45B189B1%
Annual Yield % from dividends0.001.23-
Returns for 1 year34.4822.58153%
Returns for 3 years40.3943.4493%
Returns for 5 years15.3035.1344%
Returns for 10 years87.35156.0756%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C